CPL - Chalmers Publication Library
| Utbildning | Forskning | Styrkeområden | Om Chalmers | In English In English Ej inloggad.

Influence of androgen receptor repeat polymorphisms on personality traits in men

Lars Westberg ; Susanne Henningsson ; Mikael Landén ; Kristina Annerbrink ; Jonas Melke ; Staffan Nilsson (Institutionen för matematiska vetenskaper, matematisk statistik) ; Roland Rosmond ; Göran Holm ; Henrik Anckarsäter ; Elias Eriksson
Journal of Psychiatry and Neuroscience (1488-2434). Vol. 34 (2009), 3, p. 205-213.
[Artikel, refereegranskad vetenskaplig]

Background Testosterone has been attributed importance for various aspects of behaviour. The aim of our study was to investigate the potential influence of 2 functional polymorphisms in the amino terminal of the androgen receptor on personality traits in men. Methods We assessed and genotyped 141 men born in 1944 recruited from the general population. We used 2 different instruments: the Karolinska Scales of Personality and the Temperament and Character Inventory. For replication, we similarly assessed 63 men recruited from a forensic psychiatry study group. Results In the population-recruited sample, the lengths of the androgen receptor repeats were associated with neuroticism, extraversion and self-transcendence. The association with extraversion was replicated in the independent sample. Limitations Our 2 samples differed in size; sample 1 was of moderate size and sample 2 was small. In addition, the homogeneity of sample 1 probably enhanced our ability to detect significant associations between genotype and phenotype. Conclusion Our results suggest that the repeat polymorphisms in the androgen receptor gene may influence personality traits in men.

Denna post skapades 2008-09-24. Senast ändrad 2016-06-29.
CPL Pubid: 74296


Läs direkt!

Länk till annan sajt (kan kräva inloggning)

Institutioner (Chalmers)

Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi (GU)
Institutionen för matematiska vetenskaper, matematisk statistik (2005-2016)


Övrig farmaci

Chalmers infrastruktur